L. Frontini

4.3k citations

82 papers · 2.0k indexed · 1 hit paper · h-index 20

Impact in

Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes

Papers in

Hardware and Architecture 12
- Network Packet Processing and Optimization 7
Oncology 37
- Colorectal Cancer Treatments and Studies 24
- Cancer Treatment and Pharmacology 16
- Pancreatic and Hepatic Oncology Research 8

Co-authors: Sandro Barni Vincenzo Adamo M. Marangolo Francesco Di Costanzo Cesare Gridelli Serafino Ricci A. Ceribelli Giuseppe Altavilla
Journals: British Journal of Cancer (11 papers)Annals of Oncology (11 papers)Journal of Clinical Oncology (8 papers)European Journal of Cancer (5 papers)The International Journal of Biological Markers (5 papers)
Partner nations: Italy France Australia

In The Last Decade

L. Frontini

77 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer 2002 · 739 citations

Peers

Countries citing papers authored by L. Frontini

Since Specialization

Citations

This map shows the geographic impact of L. Frontini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Frontini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Frontini more than expected).

Fields of papers citing papers by L. Frontini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Frontini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Frontini. The network helps show where L. Frontini may publish in the future.

Co-authors

The 25 scholars most cited alongside L. Frontini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Frontini Line = papers co-authored together L. Frontini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The first ASIC prototype of a 28 nm time-space front-end electronics for real-time tracking Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) ·Lorenzo Piccolo, Angelo Rivetti, S. Cadeddu, L. Casu, A. Lai, Massimo Barbaro, Corrado Napoli, Stefano Sonedda, L. Frontini, Valentino Liberali, A. Stabile, S. Shojaii	2020	4
2	Sidedness influences prognosis in colon cancer patients receiving an adjuvant therapy. A GISCAD analysis from three randomized trials including 5234 patients Annals of Oncology ·Fabio Gelsomino, Valter Torri, Alberto Zaniboni, Roberto Labianca, A. Sobrero, Davide Poli, L. Frontini, Stefano Cascinu	2017	2
3	Dihydropyrimidine dehydrogenase (DPYD) gene polymorphisms profiling in colon cancer patients treated with adjuvant chemotherapy in the randomized phase III TOSCA trial Annals of Oncology ·Francesco Graziano, Annamaria Ruzzo, Eliana Rulli, Francesca Galli, Maura Menghi, Dana Viti, Elisa Giacomini, Sara Lonardi, Monica Ronzoni, B. Massidda, Nicoletta Pella, Claudia Mucciarini, Roberto Labianca, Enzo Veltri, Pietro Sozzi, Sandro Barni, A. Sobrero, L. Frontini, Mauro Magnani	2016	1
4	Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial JNCI Journal of the National Cancer Institute ·Stefano Cascinu, Roberto Labianca, Carlo Barone, Armando Santoro, Carlo Carnaghi, Alessandra Cassano, Giordano Beretta, Vincenzo Catalano, Oscar Bertetto, Sandro Barni, L. Frontini, Enrico Aitini, S. Rota, Valter Torri, Irene Floriani	2007	71
5	Epirubicine-vinorelbine (EV) intravenous combination followed by oral vinorelbine (VNR) as first-line treatment in advanced breast cancer (ABC) patients: A POLONORD Group study Journal of Clinical Oncology ·L. Frontini, A Ardizzoia, M. Giordano, Daniele Fagnani, A. Scanni, L. Isa, Giovanni Scognamiglio, Tiziana Pressiani, Ilaria Colombo, A. Bertolini	2005	5
6	Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil British Journal of Cancer ·(unknown), Alfredo Guglielmi, Sandro Barni, Alberto Zaniboni, Nicoletta Pella, Ornella Belvedere, Giordano Beretta, Francesco Grossi, L. Frontini, Fabio Puglisi, Roberto Labianca, Alberto Sobrero	2004	1
7	Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) Annals of Oncology ·Stefano Cascinu, Roberto Labianca, Vincenzo Catalano, Sandro Barni, Francesco Ferraù, Giordano Beretta, L. Frontini, P. Foa, G. Pancera, Domenico Priolo, Francesco Graziano, M. Mare, Giuseppina Catalano	2003	22
8	Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen British Journal of Cancer ·Stefano Cascinu, Anna Maria Baldelli, Vincenzo Catalano, Paolo Giordani, Giordano Beretta, R R Silva, Giulio Gasparini, D. Mari, R. Maisano, Stefania Salvagni, Sandro Barni, Roberto Labianca, L. Frontini, C.G. Curti, Giuseppina Catalano	2002	12
9	A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer British Journal of Cancer ·Stefano Cascinu, Francesco Graziano, Sandro Barni, Roberto Labianca, G. Comella, Rossana Casaretti, L. Frontini, Vincenzo Catalano, Anna Maria Baldelli, Giuseppina Catalano	2001	40
10	Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses British Journal of Cancer ·Cesare Gridelli, L. Frontini, Federica Perrone, Ciro Gallo, Marcella Gulisano, S. Cigolari, Fabiana Castiglione, Sergio Robbiati, Giampietro Gasparini, Giovanni Pietro Ianniello, A. Farris, M.C. Locatelli, Raffaella Felletti, E. Piazza	2000	51
11	Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study Annals of Oncology ·Alberto Sobrero, Alberto Zaniboni, Giovanni Luca Frassineti, C. Aschele, Alfredo Guglielmi, Rosa Giuliani, Alessandra Ravaioli, Claudio Lanfranco, C. Caroti, Ermenegildo Arnoldi, Sandro Barni, Luigi Gallo, M.A. Pessi, D. Turci, Enrico Cortesi, Francesco Grossi, L. Frontini, E. Piazza, Paolo Bruzzi, Roberto Labianca	2000	15
12	A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) Annals of Oncology ·Stefano Cascinu, L. Frontini, Roberto Labianca, Vincenzo Catalano, Sandro Barni, Claudio Graiff, Giovanni Picone, Fabio Farinati, S. Zonato, M.A. Pessi, C.G. Curti, Giuseppina Catalano	2000	32
13	Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer Annals of Oncology ·Cecilia Nisticò, Carlo Garufi, Sandro Barni, L. Frontini, D.A.P. Gallà, Diana Giannarelli, Angela Vaccaro, A.M. D'Ottavio, E. Terzoli	1999	28
14	A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) British Journal of Cancer ·Stefano Cascinu, Rosa Rita Silva, Sandro Barni, Roberto Labianca, L. Frontini, E. Piazza, G. Pancera, Paolo Giordani, Luciano Giuliodori, M.A. Pessi, Vittorio Fusco, G Luporini, R. Cellerino, Giuseppina Catalano	1999	68
15	A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer Annals of Oncology ·Stefano Cascinu, R. R. Silva, Roberto Labianca, Sandro Barni, Rodolfo Mattioli, G. Martignoni, L. Frontini, Giulio Gasparini, Vincenzo Catalano, Anna Maria Baldelli, Luciano Giuliodori, Romina Agostinelli, G. Catalano	1999	5
16	High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study Annals of Oncology ·Roberto Labianca, Stefano Cascinu, L. Frontini, Sandro Barni, Giammaria Fiorentini, G. Comella, Alberto Zaniboni, Ornella Gottardi, Ermenegildo Arnoldi, Cristina Oliani, Mary Duro, Giovanni Pavanato, G. Martignoni, Alberto Raina, E. Piazza, G. Dallavalle, R. Valsecchi, G. Pancera	1997	20
17	Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. Journal of Clinical Oncology ·Stefano Cascinu, Roberto Labianca, Paolo Alessandroni, Massimo Marcellini, R R Silva, G. Pancera, E. Testa, G. Martignoni, Sandro Barni, L. Frontini, Alberto Zaniboni, G Luporini, R. Cellerino, Giuseppina Catalano	1997	88
18	Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study. Journal of Clinical Oncology ·Giulio Gasparini, Orazio Caffo, Sandro Barni, L. Frontini, Alessandro Testolin, R Guglielmi, G. Ambrosini	1994	133
19	Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer British Journal of Cancer ·P. Marino Gallina, Massimo Cugno, Armando Preatoni, P. Cori, Alberto Rosti, L. Frontini, Marco Cicardi	1990	29
20	[Traumatic rupture of the diaphragm caused by closed injury]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·L. Frontini, G Lucca, C Pozzi, Peter Rona	1978	1

About L. Frontini

L. Frontini is a scholar working on Hardware and Architecture, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Instrumentation, having authored 82 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (16 papers), Gastric Cancer Management and Outcomes (15 papers), Advanced Memory and Neural Computing (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Network Packet Processing and Optimization (7 papers), Breast Cancer Treatment Studies (7 papers) and Particle Detector Development and Performance (7 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (254 citations), Gastroenterology (85 citations) and Anesthesiology and Pain Medicine (67 citations). L. Frontini has collaborated with scholars based in Italy, France and Australia. Frequent co-authors include Sandro Barni, Vincenzo Adamo, M. Marangolo, Francesco Di Costanzo, Cesare Gridelli, Serafino Ricci, A. Ceribelli, Giuseppe Altavilla, Giorgio V. Scagliotti and Elide Matano. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer and The International Journal of Biological Markers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact